Home
Our Technology
Pipeline
News
About
Contact
Menu
We use cookies to improve usability.
Privacy Statement
Accept
Latest
News
All
FDA
Corporate
Grants and Funding
License Agreements
R&D
05.16.2016
Elixirgen Signs License Agreement with National Institute on Aging
11.19.2015
Elixirgen Announces License Agreement with Sumitomo Dainippon Pharma
05.31.2015
New Down syndrome therapy discovered
07.13.2012
Elixirgen awarded Investigator-Initiated Grant from MSCRF